M. Pettersson
Molecular Biology · with Crews · 2019
A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 20 citations into it
Whom M. Pettersson trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from M. Pettersson's perspective
Ordered by how strongly the researchers M. Pettersson trusts endorse each paper. Same corpus, a different order for every researcher.
- Protacs: Chimeric molecules that target proteins to the Skp1–Cullin–F box complex for ubiquitination and degradation (Proceedings of the National Academy of Sciences of the United States of America)
- Targeting IAP proteins for therapeutic intervention in cancer (Nature reviews. Drug discovery)
- The druggable genome (Nature reviews. Drug discovery)
- In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2 (Science)
- Predicting druggable binding sites at the protein-protein interface.
- Faculty Opinions recommendation of Structural basis of PROTAC cooperative recognition for selective protein degradation.
- Plasticity in binding confers selectivity in ligand induced protein degradation
- Resistance Mechanisms for the Bruton’s Tyrosine Kinase Inhibitor Ibrutinib (New England Journal of Medicine)
- Molecular mechanisms of antibiotic resistance (Nature Reviews Microbiology)
- Cancer drug resistance: an evolving paradigm (Nature Reviews. Cancer)
Their papers
- PROteolysis TArgeting Chimeras (PROTACs) - Past, Present and Future (2019) — 628 citations